IGF-I and epidermal growth factor levels in follicular fluid of women undergoing controlled ovarian hyperstimulation using the multidose GnRH-antagonist protocol or the long GnRH-agonist protocol B. AsimakopoulosB. SchöpperN. Nikolettos Rapid Communication 11 March 2014 Pages: RC5 - RC8
Currently available somatostatin analogs are not good for Graves’ orbitopathy M. L. TandaL. Bartalena Editorial 11 March 2014 Pages: 389 - 390
Growth Hormone Registry: A step forward in standard diagnostic practices in Italy M. MaghnieN. di Iorgi Editorial 11 March 2014 Pages: 391 - 392
Dehydroepiandrosterone and human adipose tissue F. SaraçS. YildizM. Tüzün Original Articles 11 March 2014 Pages: 393 - 398
Growth hormone replacement therapy in growth hormone deficient children and adults: Effects on hemochrome S. BergamaschiC. GiavoliP. Beck-Peccoz Original Articles 11 March 2014 Pages: 399 - 404
An empowerment-based educational program improves psychological well-being and health-related quality of life in Type 1 diabetes G. ForlaniC. ZannoniG. Marchesini Original Articles 11 March 2014 Pages: 405 - 412
Slow-release lanreotide in Graves’ ophthalmopathy: A double-blind randomized, placebo-controlled clinical trial T.-C. ChangS.-L. Liao Original Articles 11 March 2014 Pages: 413 - 422
The newly developed three-dimensional (3D) and two-dimensional (2D) thyroid ultrasound are strongly correlated, but 2D overestimates thyroid volume in the presence of nodules T. RagoW. BencivelliP. Vitti Original Articles 11 March 2014 Pages: 423 - 426
Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study G. PapiS. M. CorselloE. Roti Original Articles 11 March 2014 Pages: 427 - 437
Incidence and prevalence rate estimation of GH treatment exposure in Piedmont pediatric population in the years 2002–2004: Data from the GH Registry G. MigliarettiG. AimarettiF. Cavallo Original Articles 11 March 2014 Pages: 438 - 442
Persistent and moderate hypercalcemia related to an ovarian clear cell adenocarcinoma: Pre- and postoperative parathyroid hormone related-peptide and 1,25-dihydroxyvitamin D3 levels A. BenitJ. AllardP. Caron Case Report 11 March 2014 Pages: 443 - 449
MEN1 family with a novel frameshift mutation V. NuzzoL. TauchmanováA. Colao Case Report 11 March 2014 Pages: 450 - 456
An uncommon large deletion in the androgen-receptor gene in a XY female with complete androgen insensitivity syndrome C. MorettiT. OdorisioP. Grimaldi Case Report 11 March 2014 Pages: 457 - 461
Pituitary size fluctuation in long-term MR studies of PROP1 deficient patients: A persistent pathophysiological mechanism? A. VoutetakisA. SertedakiM. I. Argyropoulou Case Report 11 March 2014 Pages: 462 - 466
Preventing skeletal complications in androgen deprived men with prostate cancer: Time for action M. Braga-BasariaS. Basaria Opinion 11 March 2014 Pages: 467 - 470
Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications S. TsagarakisD. VassiliadiN. Thalassinos Review Article 11 March 2014 Pages: 471 - 482
12th International Congress on Hormonal Steroids and Hormones & Cancer Announcement 11 March 2014 Pages: 483 - 483
